Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 68,768 shares at $8.98 ($618K) on 2025-04-29, disclosed to the SEC on 2025-05-01.
Scheduled sale ($618k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.98 | 34,384 | $309K | 50.0% |
| 2 | $8.98 | 34,384 | $309K | 50.0% |
| Total | $8.98 avg | 68,768 | $618K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |
| VRNA | SELL | 2024-11-26 | $1.2M | — | Filing → |